AQR Capital Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,334
| Closed | -$830K | – | 2395 |
|
|
2022
Q2 | $830K | Sell |
25,334
-18,821
| -43% | -$595K | ﹤0.01% | 1496 |
|
|
2022
Q1 | $1.16M | Sell |
44,155
-20,061
| -31% | -$490K | ﹤0.01% | 1469 |
|
|
2021
Q4 | $1.52M | Sell |
64,216
-3,142
| -5% | -$77.5K | ﹤0.01% | 1342 |
|
|
2021
Q3 | $1.69M | Buy |
67,358
+6,032
| +10% | +$154K | ﹤0.01% | 1244 |
|
|
2021
Q2 | $1.59M | Sell |
61,326
-16,996
| -22% | -$462K | ﹤0.01% | 1349 |
|
|
2021
Q1 | $2.01M | Sell |
78,322
-7,322
| -9% | -$188K | ﹤0.01% | 1203 |
|
|
2020
Q4 | $1.72M | Sell |
85,644
-4,061
| -5% | -$79.5K | ﹤0.01% | 1239 |
|
|
2020
Q3 | $1.54M | Sell |
89,705
-24,465
| -21% | -$462K | ﹤0.01% | 1218 |
|
|
2020
Q2 | $2.49M | Buy |
114,170
+75,732
| +197% | +$1.73M | ﹤0.01% | 1055 |
|
|
2020
Q1 | $889K | Buy |
38,438
+23,784
| +162% | +$691K | ﹤0.01% | 1397 |
|
|
2019
Q4 | $483K | Buy |
14,654
+1,743
| +14% | +$55.9K | ﹤0.01% | 1760 |
|
|
2019
Q3 | $411K | Sell |
12,911
-613
| -5% | -$17.9K | ﹤0.01% | 1816 |
|
|
2019
Q2 | $347K | Buy |
13,524
+3,762
| +39% | +$95.9K | ﹤0.01% | 1834 |
|
|
2019
Q1 | $248K | Buy |
9,762
+1,218
| +14% | +$36.3K | ﹤0.01% | 2029 |
|
|
2018
Q4 | $291K | Sell |
8,544
-19,299
| -69% | -$627K | ﹤0.01% | 1972 |
|
|
2018
Q3 | $993K | Sell |
27,843
-203
| -0.7% | -$7.17K | ﹤0.01% | 1712 |
|
|
2018
Q2 | $968K | Buy |
28,046
+13,611
| +94% | +$477K | ﹤0.01% | 1734 |
|
|
2018
Q1 | $486K | Buy |
+14,435
| New | +$457K | ﹤0.01% | 1917 |
|
|
2017
Q4 | – | Sell |
-6,501
| Closed | -$244K | – | 2291 |
|
|
2017
Q3 | $244K | Sell |
6,501
-34,507
| -84% | -$1.22M | ﹤0.01% | 2130 |
|
|
2017
Q2 | $1.53M | Sell |
41,008
-5,154
| -11% | -$186K | ﹤0.01% | 1502 |
|
|
2017
Q1 | $1.81M | Buy |
46,162
+1,522
| +3% | +$57.1K | ﹤0.01% | 1424 |
|
|
2016
Q4 | $1.55M | Sell |
44,640
-31,151
| -41% | -$1.22M | ﹤0.01% | 1524 |
|
|
2016
Q3 | $2.98M | Buy |
75,791
+2,410
| +3% | +$96.1K | ﹤0.01% | 1228 |
|
|
2016
Q2 | $2.77M | Buy |
73,381
+12,913
| +21% | +$432K | ﹤0.01% | 1153 |
|
|
2016
Q1 | $2.32M | Buy |
60,468
+10,820
| +22% | +$403K | ﹤0.01% | 1182 |
|
|
2015
Q4 | $2.38M | Sell |
49,648
-54,352
| -52% | -$2.52M | ﹤0.01% | 1165 |
|
|
2015
Q3 | $4.1M | Sell |
104,000
-28,745
| -22% | -$1.22M | 0.01% | 873 |
|
|
2015
Q2 | $5.65M | Sell |
132,745
-10,688
| -7% | -$426K | 0.01% | 784 |
|
|
2015
Q1 | $5.66M | Buy |
143,433
+10,646
| +8% | +$393K | 0.01% | 733 |
|
|
2014
Q4 | $4.79M | Buy |
132,787
+23,587
| +22% | +$792K | 0.01% | 925 |
|
|
2014
Q3 | $3.22M | Buy |
109,200
+61,600
| +129% | +$1.7M | 0.01% | 1014 |
|
|
2014
Q2 | $1.2M | Buy |
47,600
+900
| +2% | +$22.3K | ﹤0.01% | 1565 |
|
|
2014
Q1 | $1.21M | Buy |
+46,700
| New | +$1.18M | ﹤0.01% | 1608 |
|
Other funds holding NTUS
AQR Capital Management's NTUS Position: Q3 2022 in Review
AQR Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 25,334 shares — an estimated $830K sold.
AQR Capital Management first reported a position in NTUS in Q1 2014 and held it in 33 quarters. The position peaked at $5.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- AQR Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- AQR Capital Management sold 25,334 Natus Medical Inc shares in Q3 2022, an estimated $830K.
- AQR Capital Management first reported a position in Natus Medical Inc in Q1 2014 and held it in 33 quarters.
- AQR Capital Management's Natus Medical Inc position peaked at $5.66M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.